Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of CSL Limited Influenza Vaccine in Adults and Older Adults (2005 Northern Hemisphere Season)
2005-000651-14Phase 4Completed
- Sponsor
- CSL Limited
- Start
- Apr 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of influenza vaccine in influenza (2 arms), sponsored by CSL Limited. Primary endpoints: Immunogenicity per CPMP/BWP/214/96 criteria and Safety of CSL Limited influenza vaccine. Started Apr 2005; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2005-000651-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000651-14.